In the current studies, we have shown that METH treatment with SH-SY5y neuroblastoma cells reduces the phosphorylation level of PI3K, Akt, and mTOR but pre-treatment with lupenone partially recovers. The gene discussed is MTOR; the disease is neuroblastoma.